Universal Health Services Set to Announce Earnings This Week

Universal Health Services, Inc. (UHS), based in King of Prussia, Pennsylvania, is a leading healthcare management company with a market capitalization of $11.3 billion. The firm manages a broad spectrum of acute care hospitals, behavioral health facilities, outpatient centers, and surgical hospitals nationwide. UHS is slated to release its fiscal Q1 earnings results on Wednesday, April 23.

Profit Projections and Past Performance

Before this announcement, analysts anticipate that the healthcare giant will report earnings of $4.36 per share, reflecting a 17.8% increase from $3.70 per share in the same quarter last year. Over the past year, the company has outperformed Wall Street’s earnings expectations in three out of four quarters, missing estimates on just one occasion. In its last quarter, UHS exceeded the consensus EPS estimate by 17.4%, thanks to strong performances in both acute care and behavioral health sectors.

Future Earnings Expectations

For fiscal 2025, analysts project UHS to achieve an EPS of $19.13, a 15.2% increase from $16.61 in fiscal 2024. Furthermore, this figure is expected to rise to $20.94 in fiscal year 2026, marking an annual growth rate of 9.5%.

Stock Performance and Trends

In the last 52 weeks, UHS shares have decreased by 1%. In comparison, the S&P 500 Index ($SPX) fell by 2.7% and the Health Care Select Sector SPDR Fund (XLV) declined by 6.1% during the same timeframe.

Recent Financial Achievements

On February 26, Universal Health announced its fourth-quarter earnings, leading to a 3.3% surge in stock price the next trading day. The company reported net revenues of $4.1 billion, an 11.1% increase year-over-year, and surpassed consensus estimates. For 2025, UHS forecasts consolidated net revenues of between $17.02 billion and $17.36 billion, with projected diluted EPS ranging from $18.45 to $19.95, indicating sustained growth confidence.

Analyst Ratings and Future Insights

Market analysts maintain a cautiously optimistic outlook on Universal Health’s stock, assigning it a “Moderate Buy” rating overall. Out of 18 analysts following the stock, eight endorse a “Strong Buy,” while 10 recommend a “Hold.”

Currently, UHS’ average analyst price target stands at $231.53, suggesting a potential upside of 34.9% from current price levels.

On the date of publication, Kritika Sarmah did not hold (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are solely for informational purposes. For more information, please view the Barchart Disclosure Policy here.

More news from Barchart

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.